Are flashcards effective for the ASCP MLS exam?

Yes. Flashcards use active recall — retrieving an answer from memory — which research shows is one of the most effective ways to make information stick, especially in short sessions spread over several days. That matters for the dense, definitional content the MLS tests, from ABO compatibility to organism identification and red cell indices.

What topics do the ASCP MLS flashcards cover?

Every ASCP BOC content area: Blood Banking (ABO/Rh, antibody work, DAT/IAT, transfusion reactions, HDFN), Chemistry (analytes, acid-base, cardiac and liver markers), Hematology (anemias, leukemias, coagulation, morphology), Microbiology (Gram stain and organism ID, susceptibility), Immunology, Urinalysis and Body Fluids, and Laboratory Operations.

Do these flashcards match the current ASCP MLS exam?

Yes. Every card is written to the ASCP Board of Certification Medical Laboratory Scientist content guideline — Blood Banking, Chemistry, Hematology, and Microbiology (each 17–22%) and Urinalysis/Body Fluids, Immunology, and Laboratory Operations (each 5–10%) — and to official guidance from AABB, CLSI, and the NIH.

How should I study with these flashcards?

Mix the modes: flip to learn, type to test recall, match for speed, and quiz to check yourself. Spend the most time on the four 17–22% benches — Blood Banking, Chemistry, Hematology, and Microbiology — which together make up about three-quarters of the exam.

Are the ASCP MLS flashcards free?

Yes — 100% free, all four study modes, no paywall and no sign-up.

Universal red cell donor

Group O — O red cells carry no A or B antigen; O negative is the emergency universal donor because it also lacks the D antigen.

Universal red cell recipient

Group AB — AB plasma has neither anti-A nor anti-B, so an AB patient can receive red cells of any ABO type.

Naturally occurring antibodies to the ABO antigen a person lacks: group A has anti-B, group B has anti-A, group O has both, group AB has neither.

Forward vs reverse ABO typing

Forward tests the patient's red cells with anti-A/anti-B reagents; reverse tests the patient's plasma against A1 and B cells. The two must agree.

A mismatch between forward and reverse typing. Resolve it (repeat with washed cells, review age/diagnosis/transfusion history) before transfusing.

Bombay phenotype (hh)

Lacks the H antigen (the A/B precursor), so no A, B, or H antigen; types as O but makes potent anti-H and needs Bombay (hh) blood.

The most immunogenic Rh antigen. Rh-negative people readily form anti-D after exposure; anti-D causes the classic severe HDFN.

Direct antiglobulin test (DAT)

Detects red cells already coated in vivo with antibody or complement; run on washed patient cells with no incubation. Used in HDFN, AIHA, transfusion reactions.

Indirect antiglobulin test (IAT)

Detects in vitro sensitization by incubating patient plasma with reagent cells; basis of the antibody screen, antibody ID, and antiglobulin crossmatch.

Anti-human globulin (AHG) reagent

The Coombs reagent that bridges IgG or complement bound to red cells, producing visible agglutination in the DAT and IAT.

Tests patient plasma against 2–3 reagent screening cells to detect clinically significant unexpected (non-ABO) antibodies before transfusion.

Donor red cells tested against recipient plasma — the clinically essential test that detects recipient antibodies that could destroy transfused cells.

Electronic (computer) crossmatch

Acceptable when the antibody screen is negative and there is no antibody history; its only remaining job is confirming ABO compatibility.

An antibody reacts more strongly with homozygous (double-dose) than heterozygous cells; classic for Kidd (Jka/Jkb) and Duffy antibodies.

Kidd antibodies (anti-Jka)

Show dosage and fall below detection between exposures, so they are missed on screening and cause delayed (anamnestic) hemolytic transfusion reactions.

Acute hemolytic transfusion reaction

The most dangerous reaction — almost always an ABO mismatch from an ID/clerical error. Fever, flank pain, and free hemoglobin in post-transfusion plasma.

Febrile non-hemolytic transfusion reaction (FNHTR)

A temperature rise of at least 1°C with chills during transfusion, without hemolysis; from recipient antibodies to donor leukocytes/cytokines.

Delayed hemolytic transfusion reaction (DHTR)

Days after transfusion: falling hemoglobin, a newly positive DAT and antibody screen — an anamnestic antibody (often Kidd) re-emerging.

Hemolytic disease of the fetus and newborn (HDFN)

Maternal IgG crosses the placenta and hemolyzes fetal red cells. Classic severe form: anti-D in a sensitized Rh-negative mother; ABO HDFN is milder.

Rh immune globulin (RhIG)

Anti-D given to D-negative mothers to prevent anti-D alloimmunization after exposure to D-positive fetal cells.

Quantifies fetal red cells in maternal blood (fetal hemoglobin resists acid) to calculate the RhIG dose after a fetomaternal hemorrhage.

20–24°C (room temperature) with continuous gentle agitation, up to 5–7 days. Never refrigerated — cold activates and clears platelets.

Washed red blood cells

Plasma (including IgA) removed; used for IgA-deficient patients or those with repeated allergic/anaphylactic reactions.

Irradiated blood components

Prevent transfusion-associated graft-versus-host disease by inactivating donor lymphocytes; used in immunocompromised recipients.

Concentrates fibrinogen, factor VIII, von Willebrand factor, and factor XIII; used for fibrinogen replacement.

Acquired B phenomenon

Bacterial deacetylase modifies the group A sugar so anti-B reagent weakly reacts; seen in gram-negative sepsis or colon carcinoma.

Lewis blood group system

Lewis antigens are adsorbed onto red cells from plasma, not synthesized by the red cells — a unique feature of the system.

Muddy-brown granular casts

The hallmark of acute tubular necrosis, formed from sloughed tubular epithelial debris.

Indicate glomerular bleeding; characteristic of acute glomerulonephritis. Casts localize the finding to the kidney.

White blood cell casts

Indicate renal inflammation/infection such as pyelonephritis.

Seen in chronic renal failure with marked urine stasis — long-standing, severe renal damage.

Renal tubular cells filled with absorbed lipid; seen in nephrotic syndrome with heavy proteinuria.

Hexagonal urine crystals

Cystine crystals — diagnostic of cystinuria, an inherited disorder of cystine transport.

Ascorbic acid (vitamin C) interference

High urine vitamin C causes falsely low or negative blood, glucose, and bilirubin reagent-strip pads.

Bacterial meningitis CSF pattern

High WBC with neutrophil predominance, high protein, and LOW glucose (bacteria consume it).

Viral meningitis CSF pattern

Lymphocyte-predominant pleocytosis with normal glucose and normal-to-mildly elevated protein.

About 60–70% of the simultaneous plasma glucose; always interpret CSF glucose against a paired plasma sample.

Distinguish a transudate from an exudate in serous fluid; meeting any one criterion (fluid:serum protein or LDH ratios, or high LDH) makes it an exudate.

Nitrite + leukocyte esterase

Reagent-strip screen for urinary tract infection; both positive strongly suggests infection.

Specific gravity (strip vs refractometer)

The reagent-strip pad reads only ionic solutes; a refractometer responds to all solutes, so they disagree with heavy non-ionic solutes like contrast media.

Na − (Cl + HCO₃), normally ~8–12 mmol/L. A high gap = metabolic acidosis from unmeasured acids (lactate, ketoacids, toxins).

Reflects average glucose over ~2–3 months; ≥6.5% is diagnostic of diabetes, 5.7–6.4% is prediabetes.

Oral glucose tolerance test (diabetes)

A 2-hour value of ≥200 mg/dL after a 75-gram glucose load is diagnostic of diabetes mellitus.

LDL = total cholesterol − HDL − (triglycerides ÷ 5); valid only when triglycerides are below ~400 mg/dL.

The most cardiac-specific and sensitive marker of myocardial injury; the standard biomarker for diagnosing myocardial infarction.

Your FREE ASCP MLS Flashcards 2026 – 100+ Cards

Realistic, ASCP-aligned MLS flashcards — flip, match, type, and quiz yourself, all at the Medical Laboratory Scientist level.

Master cards to boost your scoreMaster cards to raise your exam readiness score

How well do you know them?

ASCP MLS Flashcards

Universal red cell donor: Group O — O red cells carry no A or B antigen; O negative is the emergency universal donor because it also lacks the D antigen.
Universal red cell recipient: Group AB — AB plasma has neither anti-A nor anti-B, so an AB patient can receive red cells of any ABO type.
ABO isoagglutinins: Naturally occurring antibodies to the ABO antigen a person lacks: group A has anti-B, group B has anti-A, group O has both, group AB has neither.
Forward vs reverse ABO typing: Forward tests the patient's red cells with anti-A/anti-B reagents; reverse tests the patient's plasma against A1 and B cells. The two must agree.
ABO discrepancy: A mismatch between forward and reverse typing. Resolve it (repeat with washed cells, review age/diagnosis/transfusion history) before transfusing.
Bombay phenotype (hh): Lacks the H antigen (the A/B precursor), so no A, B, or H antigen; types as O but makes potent anti-H and needs Bombay (hh) blood.
D antigen: The most immunogenic Rh antigen. Rh-negative people readily form anti-D after exposure; anti-D causes the classic severe HDFN.
Direct antiglobulin test (DAT): Detects red cells already coated in vivo with antibody or complement; run on washed patient cells with no incubation. Used in HDFN, AIHA, transfusion reactions.
Indirect antiglobulin test (IAT): Detects in vitro sensitization by incubating patient plasma with reagent cells; basis of the antibody screen, antibody ID, and antiglobulin crossmatch.
Anti-human globulin (AHG) reagent: The Coombs reagent that bridges IgG or complement bound to red cells, producing visible agglutination in the DAT and IAT.
Antibody screen: Tests patient plasma against 2–3 reagent screening cells to detect clinically significant unexpected (non-ABO) antibodies before transfusion.
Major crossmatch: Donor red cells tested against recipient plasma — the clinically essential test that detects recipient antibodies that could destroy transfused cells.
Electronic (computer) crossmatch: Acceptable when the antibody screen is negative and there is no antibody history; its only remaining job is confirming ABO compatibility.
Dosage effect: An antibody reacts more strongly with homozygous (double-dose) than heterozygous cells; classic for Kidd (Jka/Jkb) and Duffy antibodies.
Kidd antibodies (anti-Jka): Show dosage and fall below detection between exposures, so they are missed on screening and cause delayed (anamnestic) hemolytic transfusion reactions.
Acute hemolytic transfusion reaction: The most dangerous reaction — almost always an ABO mismatch from an ID/clerical error. Fever, flank pain, and free hemoglobin in post-transfusion plasma.
Febrile non-hemolytic transfusion reaction (FNHTR): A temperature rise of at least 1°C with chills during transfusion, without hemolysis; from recipient antibodies to donor leukocytes/cytokines.
Delayed hemolytic transfusion reaction (DHTR): Days after transfusion: falling hemoglobin, a newly positive DAT and antibody screen — an anamnestic antibody (often Kidd) re-emerging.
Hemolytic disease of the fetus and newborn (HDFN): Maternal IgG crosses the placenta and hemolyzes fetal red cells. Classic severe form: anti-D in a sensitized Rh-negative mother; ABO HDFN is milder.
Rh immune globulin (RhIG): Anti-D given to D-negative mothers to prevent anti-D alloimmunization after exposure to D-positive fetal cells.
Kleihauer-Betke test: Quantifies fetal red cells in maternal blood (fetal hemoglobin resists acid) to calculate the RhIG dose after a fetomaternal hemorrhage.
Platelet storage: 20–24°C (room temperature) with continuous gentle agitation, up to 5–7 days. Never refrigerated — cold activates and clears platelets.
Washed red blood cells: Plasma (including IgA) removed; used for IgA-deficient patients or those with repeated allergic/anaphylactic reactions.
Irradiated blood components: Prevent transfusion-associated graft-versus-host disease by inactivating donor lymphocytes; used in immunocompromised recipients.
Cryoprecipitate: Concentrates fibrinogen, factor VIII, von Willebrand factor, and factor XIII; used for fibrinogen replacement.
Acquired B phenomenon: Bacterial deacetylase modifies the group A sugar so anti-B reagent weakly reacts; seen in gram-negative sepsis or colon carcinoma.
Lewis blood group system: Lewis antigens are adsorbed onto red cells from plasma, not synthesized by the red cells — a unique feature of the system.
Muddy-brown granular casts: The hallmark of acute tubular necrosis, formed from sloughed tubular epithelial debris.
Red blood cell casts: Indicate glomerular bleeding; characteristic of acute glomerulonephritis. Casts localize the finding to the kidney.
White blood cell casts: Indicate renal inflammation/infection such as pyelonephritis.
Broad and waxy casts: Seen in chronic renal failure with marked urine stasis — long-standing, severe renal damage.
Oval fat bodies: Renal tubular cells filled with absorbed lipid; seen in nephrotic syndrome with heavy proteinuria.
Hexagonal urine crystals: Cystine crystals — diagnostic of cystinuria, an inherited disorder of cystine transport.
Ascorbic acid (vitamin C) interference: High urine vitamin C causes falsely low or negative blood, glucose, and bilirubin reagent-strip pads.
Bacterial meningitis CSF pattern: High WBC with neutrophil predominance, high protein, and LOW glucose (bacteria consume it).
Viral meningitis CSF pattern: Lymphocyte-predominant pleocytosis with normal glucose and normal-to-mildly elevated protein.
Normal CSF glucose: About 60–70% of the simultaneous plasma glucose; always interpret CSF glucose against a paired plasma sample.
Light's criteria: Distinguish a transudate from an exudate in serous fluid; meeting any one criterion (fluid:serum protein or LDH ratios, or high LDH) makes it an exudate.
Nitrite + leukocyte esterase: Reagent-strip screen for urinary tract infection; both positive strongly suggests infection.
Specific gravity (strip vs refractometer): The reagent-strip pad reads only ionic solutes; a refractometer responds to all solutes, so they disagree with heavy non-ionic solutes like contrast media.
Anion gap: Na − (Cl + HCO₃), normally ~8–12 mmol/L. A high gap = metabolic acidosis from unmeasured acids (lactate, ketoacids, toxins).
Hemoglobin A1c: Reflects average glucose over ~2–3 months; ≥6.5% is diagnostic of diabetes, 5.7–6.4% is prediabetes.
Oral glucose tolerance test (diabetes): A 2-hour value of ≥200 mg/dL after a 75-gram glucose load is diagnostic of diabetes mellitus.
Friedewald equation: LDL = total cholesterol − HDL − (triglycerides ÷ 5); valid only when triglycerides are below ~400 mg/dL.
Cardiac troponin: The most cardiac-specific and sensitive marker of myocardial injury; the standard biomarker for diagnosing myocardial infarction.
CK-MB role today: With high-sensitivity troponin, CK-MB's main remaining use is estimating infarct size and detecting reinfarction (shorter half-life).
Alkaline phosphatase (ALP): Rises in cholestatic liver disease and in bone disease (bone turnover); a key cholestasis marker.
AST:ALT ratio > 2:1: Suggests alcoholic liver disease; both enzymes mark hepatocellular injury.
Lipase vs amylase: Lipase is more pancreas-specific and stays elevated longer than amylase in acute pancreatitis.
Calculated serum osmolality: 2 × Na + glucose/18 + BUN/2.8. An osmolal gap (measured − calculated) over ~10 suggests a toxic alcohol.
Respiratory vs metabolic acidosis: Both lower pH; respiratory has a high PCO₂ (moves opposite pH), metabolic has a low HCO₃ (moves with pH).
Blood gas reference ranges: pH 7.35–7.45, PCO₂ 35–45 mmHg, HCO₃ 22–26 mmol/L.
Therapeutic drug monitoring trough: The lowest (pre-dose) concentration; measured to ensure the drug stays in range and is not subtherapeutic or toxic.
Primary hyperparathyroidism pattern: High parathyroid hormone (PTH) with high serum calcium.
Cystatin C: A GFR marker unaffected by muscle mass, unlike creatinine — a more reliable estimate of glomerular filtration.
Acute intermittent porphyria test: Elevated urinary porphobilinogen is the key diagnostic finding.
Mean corpuscular volume (MCV): Average red cell size: microcytic <80 fL, normocytic 80–100 fL, macrocytic >100 fL — the first step in classifying anemia.
Microcytic anemia causes: Iron deficiency (low ferritin, high TIBC), thalassemia, anemia of chronic inflammation, sideroblastic anemia.
Macrocytic anemia causes: B12 or folate deficiency (megaloblastic — hypersegmented neutrophils), liver disease/alcohol, reticulocytosis, myelodysplastic syndrome.
Iron-deficiency anemia labs: Low ferritin, high total iron-binding capacity (TIBC), low transferrin saturation, and a microcytic hypochromic smear.
Ferritin: The body's main iron-storage protein; a low ferritin is the most specific indicator of iron deficiency.
PT / INR: Measures the extrinsic and common pathways (tissue factor, factor VII); monitors warfarin.
aPTT: Measures the intrinsic and common pathways (factors XII, XI, IX, VIII); monitors unfractionated heparin.
Vitamin-K-dependent factors: Factors II, VII, IX, and X (mnemonic 1972). Warfarin lowers them; the PT prolongs first because factor VII has the shortest half-life.
Hemophilia A vs B: Hemophilia A = factor VIII deficiency; hemophilia B (Christmas disease) = factor IX deficiency. Both prolong the aPTT.
Auer rods: Needle-shaped cytoplasmic inclusions of fused primary granules in myeloblasts — diagnostic of acute myeloid leukemia.
Philadelphia chromosome: t(9;22) translocation producing the BCR-ABL1 fusion gene — the hallmark of chronic myeloid leukemia (CML).
t(15;17) PML-RARA: Pathognomonic for acute promyelocytic leukemia (APL).
JAK2 V617F mutation: Found in most myeloproliferative neoplasms, including polycythemia vera.
Reed-Sternberg cells: Large binucleate cells diagnostic of Hodgkin lymphoma.
Schistocytes: Fragmented helmet/triangle red cells of microangiopathic hemolytic anemia (DIC, TTP, HUS); a negative DAT supports a mechanical cause.
DIC laboratory findings: Prolonged PT and aPTT, low platelets, low fibrinogen, and an elevated D-dimer from widespread clotting and fibrinolysis.
Teardrop cells (dacrocytes): Suggest myelofibrosis with extramedullary hematopoiesis.
Howell-Jolly bodies: Nuclear remnants in red cells, normally removed by the spleen; their presence indicates a post-splenectomy or hyposplenic state.
Hereditary spherocytosis test: Increased osmotic fragility — spherocytes rupture readily in hypotonic solution.
Factor V Leiden: The most common inherited thrombophilia; factor V resists inactivation by activated protein C, raising venous thrombosis risk.
Reticulocyte count stain: Supravital stains (new methylene blue) precipitate residual ribosomal RNA in reticulocytes, gauging marrow response.
Sickle cell mutation: Glutamic acid replaced by valine at position 6 of beta-globin, producing hemoglobin S and sickle-shaped cells.
IgM antibody: A pentamer, first made in the primary immune response, and the most efficient complement activator. Cannot cross the placenta.
IgG antibody: The most abundant serum immunoglobulin, dominant in the secondary response, and the only class that crosses the placenta (so it causes HDFN).
IgA antibody: The predominant immunoglobulin in mucosal secretions (GI, respiratory, urogenital tracts).
Type I hypersensitivity: Immediate, IgE-mediated mast-cell degranulation — allergy and anaphylaxis.
Type II hypersensitivity: Antibody-mediated cytotoxicity against cell-surface antigens — e.g. a hemolytic transfusion reaction.
Type III hypersensitivity: Immune-complex deposition — serum sickness and systemic lupus erythematosus.
Type IV hypersensitivity: Delayed, T-cell-mediated, appearing 48–72 hours later — contact dermatitis and the PPD (tuberculin) reaction.
Antinuclear antibody (ANA): Autoantibodies against nuclear components; the indirect immunofluorescence screen on HEp-2 cells is the gold standard for SLE.
Rheumatoid factor: An autoantibody, usually IgM, directed against the Fc region of the patient's own IgG.
MHC class I vs class II: Class I presents endogenous antigen to CD8+ cytotoxic T cells; class II presents exogenous antigen to CD4+ helper T cells.
Complement central step: Cleavage of C3 by a C3 convertase — the convergence point of the classical, alternative, and lectin pathways.
Natural killer (NK) cells: Innate lymphocytes that kill target cells without antigen-specific receptors.
Heterophile (Monospot) test: Detects heterophile IgM antibodies of infectious mononucleosis that agglutinate animal red cells and are not adsorbed by guinea pig kidney.
Syphilis serology: Nontreponemal screens (RPR/VDRL) are confirmed by treponemal tests (e.g. MHA-TP/FTA-ABS).
Gram stain interpretation: Read the reaction (color), morphology (shape), and arrangement. Gram-positive retains crystal violet (thick peptidoglycan); Gram-negative is pink.
Catalase test: Adds H₂O₂ to Gram-positive cocci; bubbling (positive) = staphylococci, no bubbling (negative) = streptococci/enterococci.
Coagulase test: Distinguishes Staphylococcus aureus (coagulase-positive, clots rabbit plasma) from coagulase-negative species like S. epidermidis.
Streptococcus pyogenes: Beta-hemolytic group A strep; catalase-negative, bacitracin- and PYR-positive.
Streptococcus pneumoniae: Alpha-hemolytic, optochin-sensitive, bile-soluble Gram-positive diplococcus.
Enterococcus identification: Catalase-negative Gram-positive cocci in chains; bile-esculin positive and grows in 6.5% NaCl.
Oxidase test: Detects cytochrome c oxidase; positive in Pseudomonas and Neisseria, negative in Enterobacterales.
Escherichia coli: Oxidase-negative, lactose-fermenting Gram-negative rod (pink on MacConkey); a common cause of UTIs.
Pseudomonas aeruginosa: Oxidase-positive non-fermenting Gram-negative rod producing blue-green pigment and a grape-like odor.
Proteus mirabilis: Urease-positive, swarming, non-lactose-fermenting Gram-negative rod.
Acid-fast stain: The Ziehl-Neelsen stain detects mycolic-acid-rich cell walls; identifies Mycobacterium species such as M. tuberculosis.
Minimum inhibitory concentration (MIC): The lowest antimicrobial concentration that visibly inhibits growth; compared to CLSI (M100) breakpoints to report susceptibility.
Kirby-Bauer disk diffusion: Gives a categorical susceptibility result from zone-of-inhibition diameters using a standardized 0.5 McFarland inoculum.
Cryptococcus neoformans: Encapsulated budding yeast seen with India ink; associated with bird droppings and severe infection in the immunocompromised.
Candida albicans germ tube: A germ tube extending from the yeast with no constriction at its base presumptively identifies Candida albicans.
Listeria monocytogenes: Motile beta-hemolytic Gram-positive rod that grows at 4°C (cold enrichment); catalase-positive.
Levey-Jennings chart: Plots daily control values against the mean with ±1, ±2, and ±3 SD bands to reveal trends and shifts in test performance.
Westgard 1₃s rule: Reject the run when one control value exceeds ±3 SD; investigate before reporting patient results.
Westgard 1₂s rule: A warning (not an automatic rejection) when one value falls between ±2 and ±3 SD; inspect with other multirules.
Accuracy vs precision: Accuracy is closeness to the true value; precision is reproducibility of repeats (measured by SD and CV). A method can be precise but inaccurate.
Proficiency testing: Blind samples sent to many labs and compared to verify a lab's accuracy against peers; a CLIA requirement for many analytes.
Delta check: Compares a patient's current result with a recent prior result; a large unexplained change flags a possible specimen mix-up or error.
CLIA: The Clinical Laboratory Improvement Amendments — federal regulations setting minimum quality standards for all U.S. clinical laboratory testing.
Sensitivity vs specificity: Sensitivity = the fraction of true positives a test detects; specificity = the fraction of true negatives it correctly identifies.
Beer's law: Absorbance is proportional to analyte concentration and path length; the basis of quantitative spectrophotometry.

To find us again, just search “Career Employer ASCP MLS”

By Career EmployerUpdated Jun 20, 2026

100+ free ASCP MLS flashcards — 4 ways to study

ASCP MLS Flashcard of the Day

The classic card. Do you know this one?

Click Study Flashcards above to open the flashcard hub — over a hundred ASCP MLS cards you can flip, match, type, or quiz yourself on. Every card is drawn from the ASCP BOC Medical Laboratory Scientist content areas, so you study exactly what the MLS exam tests.^[1] Pair them with our free practice questions and study guide.

ASCP MLS Flashcard Study Modes

Most flashcard sites give you one thing: a card to flip. Ours has four modes so you can both learn the material and prove you know it — the difference between recognizing an answer and recalling it under pressure.

Flip (Study) — the classic card. Flip term ↔ definition, shuffle the deck, and mark each card “Got it” or “Still learning.”
Match (Game) — a timed game: pair each term to its definition as fast as you can. Great for cementing blood groups, organism IDs, and red cell indices.
Type (Recall) — read the definition and type the term. Typing forces true active recall instead of passive recognition.
Quiz (Test) — multiple-choice questions generated from the cards, so you can self-test exactly like exam day.

Free ASCP MLS flashcards from Career Employer — active recall for the ASCP Medical Laboratory Scientist exam

Why Flashcards Work for the ASCP MLS Exam

Flashcards aren’t busywork — they’re built on active recall: pulling an answer out of memory strengthens it far more than re-reading notes. Pair that with spacing — short sessions across several days rather than one cram — and you retain more in less time.

That matters on the MLS, where dense, definitional content — ABO compatibility, the DAT vs IAT, the leukemia translocations, organism identification, and the coagulation pathways — must be instantly available. Used alongside our practice questions and study guide, flashcards turn review time into measurable progress.

ASCP MLS Flashcards by Topic

The cards are organized by the ASCP BOC content areas. Weight your study toward the four heaviest — Blood Banking, Chemistry, Hematology, and Microbiology are each 17–22% of the exam:^[1]

ASCP MLS content areas and their weight
ASCP MLS content area	Weight
Blood Banking	17–22%
Chemistry	17–22%
Hematology	17–22%
Microbiology	17–22%
Urinalysis & Other Body Fluids	5–10%
Immunology	5–10%
Laboratory Operations	5–10%

How to Get the Most Out of These Flashcards

Start early, review daily. Begin flashcards as you cover each content area, not the week before — a few minutes a day beats one marathon session.
Use Type and Quiz, not just Flip. Recognizing the right answer is easy; recalling and choosing it is the real test.
Drill the high-yield algorithms hardest. DAT vs IAT, the MCV anemia fork, and the Gram-stain ID tree recur across many questions — make them automatic.
Mirror the exam weighting. Spend the most time on the four 17–22% benches, which together carry about three-quarters of the points.
Lock in the classic clues. Auer rods (AML), the Philadelphia chromosome (CML), schistocytes (microangiopathy), and muddy-brown casts (ATN) are repeatable points.
Then prove it. When the cards feel easy, confirm with our practice questions — aim for 80%+ before exam day.

ASCP MLS Flashcards FAQ

Over a hundred free ASCP MLS flashcards, organized across the seven ASCP Board of Certification content areas tested on the Medical Laboratory Scientist exam — blood banking, urinalysis and body fluids, chemistry, hematology, immunology, microbiology, and laboratory operations. They're free to use with no account required.

References

1.ASCP Board of Certification (BOC). “Medical Laboratory Scientist, MLS(ASCP) — Examination Content Guideline & Outline.” ASCP.org. ↑
2.Association for the Advancement of Blood & Biotherapies (AABB). “Standards for Blood Banks and Transfusion Services.” AABB. ↑
3.National Institutes of Health / National Library of Medicine. “StatPearls (anemia, coagulation, urinalysis, microbiology identification, immunology).” NIH/NLM. ↑

Career Employer

Career Employer is the ultimate resource to help you get started working the job of your dreams. We cover topics from general career information, career searching, exam preparation with free study materials, career interviewing, and becoming successful in your career of choice.

All Posts

Career Employer’s Editorial Process

Here at Career Employer, we focus a lot on providing factually accurate information that is always up to date. We strive to provide correct information using strict editorial processes, article editing, and fact-checking for all of the information found on our website. We only utilize trustworthy and relevant resources. To find out more, make sure to read our full editorial process page here.